Intrexon | XON - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Agenus USD 15.05M 656K 2026-03
Alaunos Therapeutics USD -1.01M 175K 2026-03
Amgen USD 4.61B 777M 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD 700.4M 376.22M 2026-06
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
MacroGenics USD -33.44M 21.34M 2026-03
MannKind USD -68.23M 8.76M 2026-06
Merck USD 840M 2.72B 2026-06
Novartis USD 4.75B 515M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Xencor USD -36.6M 41.26M 2026-06